Patents by Inventor Wolfgang Jenni

Wolfgang Jenni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7695980
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Grant
    Filed: January 25, 2006
    Date of Patent: April 13, 2010
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Rupert Herrmann, Wolfgang Jenni, Heribert Maerz
  • Patent number: 7563902
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Grant
    Filed: January 25, 2006
    Date of Patent: July 21, 2009
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Rupert Herrmann, Wolfgang Jenni
  • Publication number: 20090093491
    Abstract: Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: September 28, 2006
    Publication date: April 9, 2009
    Inventors: Wolfgang Jenni, Thomas Von Hirschheydt, Edgar Voss
  • Publication number: 20080132699
    Abstract: The invention relates to a new process for the preparation of pyrazine derivatives of formula (I), which are useful as intermediates for the preparation of liquid crystalline media components or of pharmaceutically active substances.
    Type: Application
    Filed: March 31, 2005
    Publication date: June 5, 2008
    Inventors: Markus Ege, Wolfgang Jenni, Thomas Von Hirschheydt, Edgar Voss
  • Patent number: 7262306
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: August 28, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Wolfgang Jenni, Dieter Heindl, Rupert Herrmann, Hans-Peter Josel, Gunter Lampert
  • Patent number: 7179812
    Abstract: The present invention provides compounds of formula (I): their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: February 20, 2007
    Assignee: Hoffmann-la Roche Inc.
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Wolfgang Jenni, Matthias Rueth, Edgar Voss
  • Publication number: 20060199833
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Application
    Filed: January 25, 2006
    Publication date: September 7, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Rupert Herrmann, Wolfgang Jenni, Heribert Maerz
  • Publication number: 20060199223
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Application
    Filed: January 6, 2006
    Publication date: September 7, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Wolfgang Jenni, Dieter Heindl, Rupert Herrmann, Hans-Peter Josel, Gunter Lampert
  • Publication number: 20060172358
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Application
    Filed: January 25, 2006
    Publication date: August 3, 2006
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Dieter Heindl, Rupert Herrmann, Wolfgang Jenni
  • Publication number: 20050222228
    Abstract: The present invention provides compounds of formula (I): their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 6, 2005
    Inventors: Birgit Bossenmaier, Walter-Gunar Friebe, Wolfgang Jenni, Matthias Rueth, Edgar Voss
  • Publication number: 20040260084
    Abstract: The compounds of the general formula (I) wherein R1 denotes a pharmaceutically acceptable side chain radical as used conventionally in the field of cephalosporins and wherein R2 denotes a pharmaceutically acceptable group which is bonded to the remaining part of the molecule by an oxygen-carbon single bond or a nitrogen-carbon single bond, and their pharmaceutically acceptable salts, esters and amide derivatives are effective antibiotics.
    Type: Application
    Filed: March 26, 2004
    Publication date: December 23, 2004
    Inventors: Hans R. Pfaendler, Wolfgang Jenni